CF
New number, same fertilizer drama
CF Industries got a fresh little boost from Barclays on April 17, 2026: the bank slapped on an Overweight rating and nudged its price target up to $130 from $120. For a stock trading around $112.70, that’s Barclays basically saying, “Yeah, we still like this one.”
Why traders care
CF isn’t some flashy AI rocket ship. It makes nitrogen fertilizers, which is a far less glamorous but very real way to make money when global food demand keeps doing its thing. Barclays’ move suggests the firm thinks CF’s setup still looks solid enough to outperform, even after a decent run.
But valuation isn’t exactly dirt cheap
There’s a tiny catch here: GuruFocus pegs CF at 11.6% overvalued versus its GF Value estimate, and the stock’s P/E of 12.52x sits above its 5-year median of 11.32x. So the message is less “bargain bin” and more “premium brand, but maybe worth it.”
The fine print investors will side-eye
- GF Score: 81/100, which screams solid fundamentals
- Profitability: 9/10, because making nitrogen apparently pays when done right
- Momentum: 3/10, so the stock isn’t exactly sprinting
- Insider selling: $72.2 million over the past three months, which is the kind of detail that makes investors raise an eyebrow
Big picture: Barclays is telling you CF still deserves a seat at the grown-ups’ table, but the stock isn’t exactly priced like a sleepy utility. The bulls have a case — just not a cheap one.